5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)
Title:
5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)
Author:
Brown, Jennifer R. Jahn, Thomas M. Furman, Richard R. Leonard, John P. Spurgeon, Stephen E. Byrd, John C. Benson, Don M. Coutre, Steven E. Wagner-Johnston, Nina D. Flinn, Ian W. Kahl, Brad S. Schreeder, Marshall T. de Vos, Sven Holes, Leanne M. Peterman, Harriet (Sissy) Johnson, Dave M. Miller, Langdon L.